Sixteen postmenopausal women underwent electrophysiologic study before and
20 minutes after the administration of sublingual estradiol 17 beta or plac
ebo. Estradiol 17 beta significantly affected electrophysiologic parameters
, thereby suggesting its role in the development of palpitations in women.